Technologies
Novel Formulation Platform

As an experienced company for 505(b)(2) product development, we are focusing on novel formulations of problematic drugs from early stage development to commercial manufacturing. From preclinical study to commercial manufacture, multiple methods will be applied to balance risk assessment, milestone target and investment.

 

-Controlled Release Dosage

 

-Spray Dry Dispersion

 

-Hot Melt Extrusion 


-Nanosuspension



Tel: +86-755-86007001   Email: info@hlkpharma.com